Immunogenicity to infliximab is associated with HLA-DRB1

Thomas Billiet; Niels Vande Casteele; Thomas Van Stappen; Fred Princen; Sharat Singh; Ann Gils; Marc Ferrante; Gert Van Assche; Isabelle Cleynen; Severine Vermeire

doi:10.1136/gutjnl-2015-309698

Article info

PostScript

Letter

Immunogenicity to infliximab is associated with HLA-DRB1

Authors

Thomas Billiet Department of Clinical and Experimental Medicine, Translational Research Center for GastroIntestinal Disorders (TARGID), KU Leuven, Leuven, Belgium PubMed articles Google scholar articles
Niels Vande Casteele Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium PubMed articles Google scholar articles
Thomas Van Stappen Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium PubMed articles Google scholar articles
Fred Princen Department of Research and Development, Prometheus Laboratories, San Diego, California, USA PubMed articles Google scholar articles
Sharat Singh Department of Research and Development, Prometheus Laboratories, San Diego, California, USA PubMed articles Google scholar articles
Ann Gils Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium PubMed articles Google scholar articles
Marc Ferrante Department of Gastroenterology, UZ Leuven, Leuven, Belgium PubMed articles Google scholar articles
Gert Van Assche Department of Gastroenterology, UZ Leuven, Leuven, Belgium PubMed articles Google scholar articles
Isabelle Cleynen Department of Gastroenterology, UZ Leuven, Leuven, Belgium PubMed articles Google scholar articles
Severine Vermeire Department of Gastroenterology, UZ Leuven, Leuven, Belgium PubMed articles Google scholar articles

Correspondence to Dr Severine Vermeire, Gastroenterology Department, University Hospitals Leuven, Herestraat 49, Leuven B-3000, Belgium; severine.vermeire{at}uzleuven.be

View Full Text

Citation

Billiet T, Vande Casteele N, Van Stappen T, et al

Immunogenicity to infliximab is associated with HLA-DRB1

Gut 2015;64:1344-1345.

Publication history

Received March 30, 2015
Accepted March 31, 2015
First published April 15, 2015.

Online issue publication

April 18, 2016

Article Versions

Previous version (18 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password